ReviewJournal of cancer research and clinical oncology2023

HER2/neu-based vaccination with li-Key hybrid, GM-CSF immunoadjuvant and trastuzumab as a potent triple-negative breast cancer treatment.

Yihan ZhouPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.